Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial
Pharma
Akebia sketches out pivotal Vafseo study in nondialysis patients
Akebia plans to kick off a phase 3 trial to assess Vafseo as a potential treatment for anemia in late-stage CKD patients who aren’t on dialysis.
Fraiser Kansteiner
Mar 13, 2025 3:28pm
Incyte posts mixed Opzelura results in prurigo nodularis
Mar 10, 2025 11:23am
Tenpoint preps FDA filing after scoring in presbyopia study
Jan 9, 2025 3:39pm
Eisai ends lorcaserin development in Dravet syndrome
Nov 18, 2024 10:18am
Aspen Neuroscience levels up in-house cell therapy production
Oct 2, 2024 8:15am
J&J nixes Tremfya trial in giant cell arteritis
Jun 25, 2024 4:45pm
